Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMAG Pharmaceuticals Inc

+ Add to Watchlist

AMAG:US

66.3500 USD 0.1700 0.26%

As of 20:10:00 ET on 05/22/2015.

Snapshot for AMAG Pharmaceuticals Inc (AMAG)

Open: 66.2700 Day's Range: 65.3300 - 66.9400 Volume: 479,738
Previous Close: 66.1800 52wk Range: 17.3450 - 68.2300 1-Yr Rtn: +278.06%

Stock Chart for AMAG

No chart data available.
  • AMAG:US 66.3100
  • 1D
  • 1M
  • 1Y
66.1800
Interactive AMAG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMAG

Current P/E Ratio (ttm) 12.5923
Estimated P/E(12/2015) 12.8411
Relative P/E vs. SPX 0.6702
Earnings Per Share (USD) (ttm) 5.2691
Est. EPS (USD) (12/2015) 5.1670
Est. PEG Ratio -
Market Cap (M USD) 2,025.84
Shares Outstanding (M) 30.53
30 Day Average Volume 805,079
Price/Book (mrq) 2.5307
Price/Sale (ttm) 8.4987
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMAG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMAG

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

William K HeidenChief Executive OfficerFrank E ThomasPresident/COO
Kenneth A WilsonPres:Lumara Health/Senior VP:Sales & MktgScott A HolmesSenior VP:Finance/CAO
More Company Profile & Key Executives for AMAG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil